Africa: First Malaria Drug for Newborns Gets Who Approval

Africa: First Malaria Drug for Newborns Gets Who Approval

The World Health Organization (WHO has approved the first malaria treatment made for newborns and very young infants, in an effort to improve care for children most at risk.

WHO prequalifies first malaria treatment for newborns

The World Health Organisation (WHO) has announced the prequalification of the first malaria treatment specifically designed for newborns and young infants.   The announcement means the medicine meets international standards for quality, safety and efficacy, and can now be procured for public health use.   The newly approved treatment, artemether-lumefantrine, is tailored for babies weighing between two and five kilogrammes, making it the first a…

First malaria drug for newborns gets WHO approval

The World Health Organization (WHO has approved the first malaria treatment made for newborns and very young infants, in an effort to improve care for children most at risk. ALSO READ: New malaria drug for newborns gets approval The medicine, artemether-lumefantrine, is designed for babies weighing between two and five kilograms. Until now, infants with malaria were treated using drugs meant for older children, which led to challenges with corre…